Oral Drug Delivery Resources
-
New Technologies To Improve Solubility Of Brick Dust Compounds
7/13/2022
David Lyon, Ph.D., and Molly Adam answer attendee questions from a recent webinar about three enabling technologies designed to improve drug solubility in organic solvents for spray drying.
-
An Integrated Radiolabelled Study: Determine Mass Balance Metabolite Profile & Absolute Bioavailability
3/3/2022
The study assessed the absorption and disposition of nolasiban after oral and IV administrations and enabled determination of mass balance, routes and rates of excretion and metabolism and absolute bioavailability.
-
Platform Reduces Product Development Time And Cost By 30%
3/4/2022
Using innovative capsule-filling equipment and processing technology, and mini-tablet and drug-layered beadlet manufacturing, you can have an adaptable, easily modified formulation.
-
Enhancing The Solubility Of High Lipophilicity Drugs Via Spray Drying
3/10/2023
A new R&D project shows the solubility and dissolution characteristics of Itraconazole can be improved by helping them maintain an amorphous state after spray drying with selected hydrophilic polymers.
-
Development Of Next Gen Sustained Release Solutions For Pain Management
2/22/2023
A TheraPEA™ polymer based injectable formulation designed to deliver the same dose of Triamcinolone Acetonide (TAA) as in Zilretta® has shown promising results in a series of pre-clinical studies.
-
Capsule Formulation Development: From Dosage Forms To Filling
5/4/2022
Capsules are tasteless and easy to take, offer streamlined development timelines, and simplicity of manufacturing. Discover capsule formulation development and the benefits of capsule dosage forms.
-
The Secrets Of A Successful CDMO Partnership
6/30/2025
From managing supply chain disruptions to maintaining a strong customer-first culture, Steven Selling offers a candid look at the strategies that help turn operational challenges into shared success.
-
Increasing Bioavailability With Amorphous Solid Dosage Formulations
11/10/2023
Discover the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how leveraging ASD formulation can help create more effective, patient-friendly drug products.
-
Making A Case For A Fixed Dose Combination Drug Strategy
As patient-centricity spurs innovation in drug delivery systems, examine the potential of FDCs to provide convenient dosing and how increased patient compliance is alleviating the cost of health care.
-
Partnering For Success In Sustained Drug Delivery Formulations
3/18/2022
With a focus on the sustained and controlled drug delivery segment of the pharmaceutical market, learn about technology platforms, support services, and sustainable solutions.